1: Li Q, Wan J, Lan X, Han X, Wang Z, Wang J. Neuroprotection of brain-permeable
iron chelator VK-28 against intracerebral hemorrhage in mice. J Cereb Blood Flow
Metab. 2017 Sep;37(9):3110-3123. doi: 10.1177/0271678X17709186. Epub 2017 May
23. PMID: 28534662; PMCID: PMC5584702.
2: Shachar DB, Kahana N, Kampel V, Warshawsky A, Youdim MB. Neuroprotection by a
novel brain permeable iron chelator, VK-28, against 6-hydroxydopamine lession in
rats. Neuropharmacology. 2004 Feb;46(2):254-63. doi:
10.1016/j.neuropharm.2003.09.005. PMID: 14680763.
3: Youdim MB, Fridkin M, Zheng H. Bifunctional drug derivatives of MAO-B
inhibitor rasagiline and iron chelator VK-28 as a more effective approach to
treatment of brain ageing and ageing neurodegenerative diseases. Mech Ageing
Dev. 2005 Feb;126(2):317-26. doi: 10.1016/j.mad.2004.08.023. PMID: 15621213.
4: Bandyopadhyay S, Huang X, Cho H, Greig NH, Youdim MB, Rogers JT. Metal
specificity of an iron-responsive element in Alzheimer's APP mRNA 5'untranslated
region, tolerance of SH-SY5Y and H4 neural cells to desferrioxamine, clioquinol,
VK-28, and a piperazine chelator. J Neural Transm Suppl. 2006;(71):237-47. doi:
10.1007/978-3-211-33328-0_25. PMID: 17447434.
5: Youdim MB, Stephenson G, Ben Shachar D. Ironing iron out in Parkinson's
disease and other neurodegenerative diseases with iron chelators: a lesson from
6-hydroxydopamine and iron chelators, desferal and VK-28. Ann N Y Acad Sci. 2004
Mar;1012:306-25. doi: 10.1196/annals.1306.025. PMID: 15105275.
